Dr Reddy's Laboratories (FRA:RDDA) Total Tax Payable: €39 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:RDDA Dr Reddy's Laboratories Ltd FRA:RDDA
93 GF Score
Price €10.30
GF Value €11.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dr Reddy's Laboratories Total Tax Payable?

Dr Reddy's Laboratories FRA:RDDA 93 Total Tax Payable is €39 Mil as of Jun. 2026. GuruFocus rates FRA:RDDA with a GF Score™ of 93/100 and a GF Value™ of €11.89 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Dr Reddy's Laboratories's Total Tax Payable for the quarter that ended in Jun. 2026 was €39 Mil.

Dr Reddy's Laboratories's quarterly Total Tax Payable declined from Dec. 2025 (€53 Mil) to Mar. 2026 (€40 Mil) and declined from Mar. 2026 (€40 Mil) to Jun. 2026 (€39 Mil).

Dr Reddy's Laboratories's annual Total Tax Payable increased from Mar. 2024 (€26 Mil) to Mar. 2025 (€32 Mil) and increased from Mar. 2025 (€32 Mil) to Mar. 2026 (€40 Mil).

Dr Reddy's Laboratories Total Tax Payable Related Terms

Dr Reddy's Laboratories Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Dr Reddy's Laboratories's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories Total Tax Payable Chart

Dr Reddy's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.25 24.34 25.95 32.37 40.17

Dr Reddy's Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 106.22 73.58 53.07 40.17 38.94
FRA:RDDA
93GF Score
Dr Reddy's Laboratories Ltd FRA:RDDA
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr Reddy's Laboratories Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of €39 Mil mean?
Dr Reddy's Laboratories (FRA:RDDA) has a Total Tax Payable of €39 Mil as of Jun. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Dr Reddy's Laboratories and its competitors.
Is Dr Reddy's Laboratories' Total Tax Payable too high?
Dr Reddy's Laboratories' current Total Tax Payable is €39 Mil. Overall, Dr Reddy's Laboratories has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Reddy's Laboratories' Total Tax Payable compare to ZTS?
Dr Reddy's Laboratories' Total Tax Payable of €39 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Dr Reddy's Laboratories and its competitors. Dr Reddy's Laboratories's current Total Tax Payable is €39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Reddy's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Dr Reddy's Laboratories (FRA:RDDA) is currently considered Modestly Undervalued. The stock's GF Value™ is €11.89, compared to a current price of €10.30 — trading 13.4% below its estimated fair value. The current Total Tax Payable is €39 Mil. Dr Reddy's Laboratories' overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Dr Reddy's Laboratories (FRA:RDDA), the current Total Tax Payable is €39 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr Reddy's Laboratories (FRA:RDDA) Overvalued in 2026?

Based on GuruFocus' analysis, Dr Reddy's Laboratories stock appears to be undervalued. The current stock price of €10.30 is trading 13.4% below its estimated GF Value™ of €11.89. GuruFocus considers Dr Reddy's Laboratories to be Modestly Undervalued.

Key valuation signals for FRA:RDDA:

  • Total Tax Payable: €39 Mil
  • GF Value™: €11.89 vs. price of €10.30 (13.4% below fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the FRA:RDDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr Reddy's Laboratories Business Description

Address 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
93GF Score

Get the complete analysis for FRA:RDDA

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.30
Price
€11.89
GF Value